Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Important safety warning seek urgent medical attention if you experience any of the following: Severe or persistent abdominal pain (which may indicate acute pancreatitis) Right upper quadrant pain, fever, or jaundice (which may indicate gallbladder disease) Reduced urine output, dizziness, or signs of dehydration (which may indicate acute kidney injury) Severe nausea or vomiting preventing adequate fluid intake Signs of a serious allergic reaction (swelling, difficulty breathing, rash) Symptoms of hypoglycaemia such as dizziness, sweating, or confusion These may represent serious adverse effects requiring prompt clinical assessment
doi: 10.1172/jci.insight.141299 124 YaoXZhangYHaoJDuanHQZhaoCXSunCet al
Bringing a new drug to the market is a long, expensive process, and one that excited consumers are easily bypassing
The dataset connects claims, labs and EHR, including physician notes to analyse: Who meets drug label or payer criteria based on actual BMI and comorbidities How titration and dosing progress in real-world care What metabolic outcomes patients achieve over time Which safety signals, such as liver or renal changes, emerge across populations Why patients discontinue or switch treatments, as documented in notes See real-world GLP-1 evidence in action Register for our webinar where we dive deeper into GLP-1 real-world evidence
Manter em temperatura ambiente (15 a 30 C)
